Medical MisinformationNCT07601308
Impact of Online Medical Misinformation
An observational study of Medical Misinformation and Medication Adherence, run by Alexandria University at 1 site in Egypt.
Trial summary
A cross-sectional analytical study was conducted among adult patients diagnosed with chronic diseases to assess the impact of online medical misinformation on medication adherence, treatment decision-making, and health care-seeking behavior. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Medical Misinformation, Medication Adherence, Health-Seeking Behavior
- What is being tested?
- None (observational)
- How many people
- 402 participants
- Where
- 1 siteEgypt
- Study dates
- 20 May 2026to 30 Jul 2026
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adult patients with chronic diseases attending outpatient clinics, who actively use social media and are exposed to online medical information.
Who may be able to join
- Adults ≥ 18 years
- Disease duration ≥ 6 months
- Social media use at least once weekly
- Able to provide informed consent
Who cannot join
- Severe cognitive or psychiatric disorders
Trial locations and contacts
1 site in 1 country.
Egypt1 site
Faculty of Nursing, Alexandria University
Alexandria, Alexandria Governorate, 21511
About this study
Official title: Online Health Misinformation and Its Association With Medication Adherence, Treatment Decision-making, and Health Care-Seeking Behavior Among Patients With Chronic Diseases: A Cross-sectional Study
A cross-sectional analytical study was conducted among adult patients diagnosed with chronic diseases to assess the impact of online medical misinformation on medication adherence, treatment decision-making, and health care-seeking behavior.
- Conditions
- Medical Misinformation, Medication Adherence, Health-Seeking Behavior, Chronic Diseases, Diabetes (DM), Hypertension (HTN)
- Being tested
- None (observational)
- Keywords
- Online Misinformation, Chronic Disease, Medication Adherence
- Medical subject headings
- Medication Adherence, Health Behavior, Chronic Disease, Diabetes Mellitus, Hypertension
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
None (observational)Other
None (observational)
| Study group | Role | What they receive |
|---|---|---|
| Single Cohort: Adults With Chronic Diseases Exposed to Online Medical Information | Not described Receives: Other: None (observational) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Medication Adherence (MARS-5 Score)
Description: Measures adherence to prescribed medications
Measured: At baseline survey assessment
Healthcare-Seeking Behavior Score
Measured: At baseline survey assessment
Treatment Decision Changes (OHIU-CD Subscale)
Measures changes in treatment decisions influenced by online information
Measured: At baseline survey assessment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 May 2026
- Study start20 May 2026
- Primary completion30 Jun 2026
- Study completion30 Jul 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Medical MisinformationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 402 participants (actual)
Sponsor and investigators
- Lead sponsor
- Alexandria University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohamed Fakhry Ahmed Salem, Alexandria University
- Investigators
- Mohamed Fakhry Ahmed Salem, PHD, Principal investigator, Alexandria University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07601308
- Sponsor's protocol ID
- AU-20-10-476
- Status last verified
- May 2026
- First submitted
- 9 May 2026
- Last updated
- 13 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No